Back to Search
PETER LANGMUIR, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1295151488Individual
Specialties, Licenses & Credentials
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
MD059042L(PA)
Research & Publications (8)
Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
PMID 19447868·Clin Cancer Res·2009
8-other
Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20.
PMID 17878480·J Clin Oncol·2007
3-trial
Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126.
PMID 15173071·Clin Cancer Res·2004
7-preclinical
Allograft rejection in a new allospecific CD4+ TCR transgenic mouse.
PMID 12694059·Am J Transplant·2003
7-preclinical
Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.
PMID 12045261·J Clin Invest·2002
7-preclinical
Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.
PMID 11145675·J Immunol·2001
4-observational
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells.
PMID 10648399·Blood·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1250 S COLLEGEVILLE RD
COLLEGEVILLE, PA 19426 - Phone
- (215) 805-3112
Quick Facts
- NPI
- 1295151488
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile